Thorsten Mikoteit
Biographic Data
| ID | 6949521 |
|---|---|
| NAME | Thorsten Mikoteit |
| GIVEN NAMES | Thorsten |
| FAMILY NAME | Mikoteit |
| SIGNATURE | MIKOTEIT T |
| AFFILIATIONS | Schweizerische Ärztegesellschaft für Psycholytische Therapie |
| ORCID | 0000-0003-2166-6330 |
| VERIFIED | Yes |
| TOTAL WORKS | 7 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 7 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Recurrent high creatine kinase levels under clozapine treatment - a case report assessing a suspected adverse drug reaction
Suspected adverse drug reactions (ADRs) during treatment with clozapine often prompt therapeutic drug monitoring (TDM) in clinical practice. Currently, there is no official recommendation for pharmacogenetic (PGx) testing in the context of clozapine therapy. In this case report, we demonstrate and discuss the challenges of interpreting PGx and TDM results highlighting the possibilities and limitations of both analytical methods. A 36-year-old mal…
Correspondence between the Simple Physical Activity Questionnaire (Simpaq) and accelerometer-based physical activity in inpatients treated for major depressive disorders in comparison to non-depressed…
Introduction Major depressive disorders (MDD) are a leading health concern worldwide. While first line medication treatments may fall short of desired therapeutic outcomes, physical activity (PA) interventions appear to be a promising and cost-effective add-on to improve symptoms of depression. This study aimed to address challenges in the assessment of PA in inpatients treated for MDD by examining the correspondence of self-reported and accelero…
Cardiorespiratory fitness and cardiovascular risk among in-patients with depression compared to healthy controls
Patients with depression and healthy controls differ in several cardiovascular risk markers, putting patients at increased risk for CVDs. In contrast, people with good CRF show more favourable cardiovascular risk scores, a relationship which was observed in both healthy controls and patients with depression. Physical health of psychiatric patients should receive the clinical attention that it deserves. Lifestyle interventions targeting healthy di…
Short-term outcomes of physical activity counseling in in-patients with Major Depressive Disorder
https://www.isrctn.com/ISRCTN10469580, identifier ISRCTN10469580
Predictors of Embarrassment in Daily Social Interactions in Social Phobia, Major Depression and Healthy Controls
Introduction: Embarrassment is a social affect. Once experienced in social interactions (SIs), it can be a precursor of clinical symptoms like depersonalization and ruminative thinking. This experience sampling study investigated predictors of embarrassment in social phobia (SP), major depressive disorder (MDD), and controls. Methods: For seven days, a total of n = 165 patients (n = 47 SP, n = 118 MDD) and n = 119 controls completed five surveys …
Case report
We report the case of a 50-year-old male with major depressive disorder (MDD) to illustrate the challenge of finding effective antidepressant pharmacotherapy and the role that the patient's genetic makeup may play. Recent treatment attempts before clinic admission included venlafaxine and fluoxetine. Venlafaxine was discontinued due to lack of response, and subsequently switched to fluoxetine based on pharmacogenotyping of the P-glycoprotein tran…
Psychosocial Health and Physical Activity in People With Major Depression in the Context of Covid-19
Introduction: Major depression is a psychiatric disease associated with physical inactivity, which in turn affects mental and physical health. A randomized controlled trial is being implemented to facilitate physical activity in people with major depression. In March 2020, Swiss state authorities temporarily legislated a lockdown to contain the Coronavirus disease-19 (COVID-19), which influenced health, behavior and research. The aim of this stud…
No prominent works on this page.
Psychosocial Health and Physical Activity in People With Major Depression in the Context of Covid-19
Introduction: Major depression is a psychiatric disease associated with physical inactivity, which in turn affects mental and physical health. A randomized controlled trial is being implemented to facilitate physical activity in people with major depression. In March 2020, Swiss state authorities temporarily legislated a lockdown to contain the Coronavirus disease-19 (COVID-19), which influenced health, behavior and research. The aim of this stud…
Predictors of Embarrassment in Daily Social Interactions in Social Phobia, Major Depression and Healthy Controls
Introduction: Embarrassment is a social affect. Once experienced in social interactions (SIs), it can be a precursor of clinical symptoms like depersonalization and ruminative thinking. This experience sampling study investigated predictors of embarrassment in social phobia (SP), major depressive disorder (MDD), and controls. Methods: For seven days, a total of n = 165 patients (n = 47 SP, n = 118 MDD) and n = 119 controls completed five surveys …
Case report
We report the case of a 50-year-old male with major depressive disorder (MDD) to illustrate the challenge of finding effective antidepressant pharmacotherapy and the role that the patient's genetic makeup may play. Recent treatment attempts before clinic admission included venlafaxine and fluoxetine. Venlafaxine was discontinued due to lack of response, and subsequently switched to fluoxetine based on pharmacogenotyping of the P-glycoprotein tran…
Cardiorespiratory fitness and cardiovascular risk among in-patients with depression compared to healthy controls
Patients with depression and healthy controls differ in several cardiovascular risk markers, putting patients at increased risk for CVDs. In contrast, people with good CRF show more favourable cardiovascular risk scores, a relationship which was observed in both healthy controls and patients with depression. Physical health of psychiatric patients should receive the clinical attention that it deserves. Lifestyle interventions targeting healthy di…
Short-term outcomes of physical activity counseling in in-patients with Major Depressive Disorder
https://www.isrctn.com/ISRCTN10469580, identifier ISRCTN10469580
Recurrent high creatine kinase levels under clozapine treatment - a case report assessing a suspected adverse drug reaction
Suspected adverse drug reactions (ADRs) during treatment with clozapine often prompt therapeutic drug monitoring (TDM) in clinical practice. Currently, there is no official recommendation for pharmacogenetic (PGx) testing in the context of clozapine therapy. In this case report, we demonstrate and discuss the challenges of interpreting PGx and TDM results highlighting the possibilities and limitations of both analytical methods. A 36-year-old mal…
Correspondence between the Simple Physical Activity Questionnaire (Simpaq) and accelerometer-based physical activity in inpatients treated for major depressive disorders in comparison to non-depressed…
Introduction Major depressive disorders (MDD) are a leading health concern worldwide. While first line medication treatments may fall short of desired therapeutic outcomes, physical activity (PA) interventions appear to be a promising and cost-effective add-on to improve symptoms of depression. This study aimed to address challenges in the assessment of PA in inpatients treated for MDD by examining the correspondence of self-reported and accelero…
Medicine (6 works) · Psychiatry (5 works) · Psychology (5 works) · Clinical Psychology (3 works) · Depression (economics (3 works) · Eating Disorders and Behaviors (3 works) · Internal Medicine (3 works) · Physical Activity and Health (3 works) · Physical therapy (3 works) · Cardiac Health and Mental Health (2 works)